NASDAQ · SBFMW
Healthcare · Drug Manufacturers - Specialty & Generic
$0.03
Up+$0.00 (+0.00%)
Updated Sep 14, 2026, 12:30 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 4 trading sessions · Daily adjusted prices
SBFMW closed at $0.03 after 4 trading sessions, up 0.00% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | $0.0311 | $0.0311 | $0.031 | $0.031 | 4.39K |
| Aug 25, 2026 | $0.031 | $0.0405 | $0.031 | $0.0405 | 1.65K |
| Aug 19, 2026 | $0.0499 | $0.0499 | $0.0499 | $0.0499 | 134 |
| Aug 17, 2026 | $0.031 | $0.031 | $0.031 | $0.031 | 2.66K |
The latest Smart Investors Daily articles mentioning SBFMW.
SBFMW research
Company profile and research snapshot.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Aug 31, 2026
FORT LAUDERDALE, FL / ACCESS Newswire / August 31, 2026 / (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its Atenolol tablets of 25mg, 50mg and 100mg for the Canadian market. Atenolol is the generic equivalent of the brand name, Tenormin®.
Yahoo · Aug 26, 2026
A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision OncologyNEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of giving the immune system a one-size-fits-all treatment, an mRNA vaccine can be designed to teach it what a particular tumor looks lik
Yahoo · Aug 26, 2026
Sunshine Biopharma Inc. (NASDAQ:SBFM) on Wednesday released an update regarding its proprietary oncology initiative, outlining key next steps for its K1.1 mRNA lipid nanoparticle program. K1.1 mRNA Preclinical Results The K1.1 mRNA gene acts as a tumor suppressor frequently mutated in hepatocellular carcinoma, non-small cell lung cancer, and pancreatic cancer. These genetic mutations form “cold” tumors that evade host immune responses, leading to poor prognosis in patients. Preclinical studies c
Yahoo · Aug 19, 2026
Global anti-hypertensive drug market projected to reach $37.24 billion by 2034 Enalapril is a widely prescribed ACE inhibitor used to treat hypertension, heart failure and left ventricular dysfunction Sunshine Biopharma expects Enalapril tablets in ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SBFMW.
No results
No recent SID articles mention SBFMW.
